Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention

Published:2005-09 Issue:5 Volume:46 Page:761-769
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Beinart Sean C.,Kolm Paul,Veledar Emir,Zhang Zefeng,Mahoney Elizabeth M.,Bouin Olivier,Gabriel Sylvie,Jackson Joseph,Chen Roland,Caro Jaime,Steinhubl Steven,Topol Eric,Weintraub William S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study;Bertrand;Circulation,1998

2. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting;Leon;N Engl J Med,1998

3. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents;Schomig;N Engl J Med,1996

4. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients;Urban;Circulation,1998

5. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

2. Association of CYP2C19*2 polymorphisms and high on-treatment platelet reactivity in acute myocardial infarction or coronary artery in-stent restenosis patients during dual antiplatelet therapy;Medicine in Drug Discovery;2020-06

3. The Role of Clopidogrel in 2020: A Reappraisal;Cardiovascular Therapeutics;2020-03-27

4. Quality of health economic evaluations for the ACC/AHA stable ischemic heart disease practice guideline: A systematic review;American Heart Journal;2018-10

5. Reducing the Global Burden of Cardiovascular Disease, Part 2;Circulation Research;2017-09